On December 24, Glonghui reported that BEIGENE (BGNE.US) increased by about 1.6% pre-market, reaching $180.53. In news, BEIGENE announced that to reflect the company's steadfast commitment to providing innovative cancer drugs globally, the stock code for its American Depositary Shares listed on Nasdaq will change from "BGNE" to "ONC," effective January 2, 2025. (Glonghui)
美股异动｜百济神州盘前涨约1.6% 拟变更美股代码 重申致力于提供创新肿瘤药物的承诺
US stock movement | BEIGENE pre-market up about 1.6%, plans to change its US stock code, reaffirms commitment to providing innovative cancer drugs.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.